Acquisition strengthens Zoetis’ leadership in precision animal health by integrating Neogen’s global genomics capabilities, expanding predictive insights and individualized care worldwide.

Wrapping up Q4 earnings, we look at the numbers and key takeaways for the life sciences tools & services stocks, including 10x Genomics (NASDAQ:TXG) and its peers.

AGBT is also, increasingly, a showcase for instruments for spatial biology, a fast-growing field that involves pinpointing the location of RNA and protein molecules en masse. Tarbox calls the meeting ...

Replacement heifer selection has always shaped herd direction. Today, genomic tools are reshaping how confidently those decisions are made.

Animal health company Zoetis and Neogen Corporation, a food and animal safety solution provider, have entered into a definitive acquisition agreement. Under the $160 million deal, ...

Collaboration, partnership, and clinical integration are key.

By combining high-resolution genomic data with AI, researchers are uncovering the regulatory logic plants use to sense and survive environmental stress.

In the assessment of 12-month price targets, analysts unveil insights for 10x Genomics, presenting an average target of ...

Zoetis (NYSE:ZTS) has entered into a definitive agreement to acquire Neogen Corporation's animal genomics business. The ...

Complete Genomics, a U.S.-based, innovator in genomic sequencing platforms and solutions, today announced it is commencing shipments of DNBSEQ-T7+ high-throughput sequencing platform at the 2026 ...

The Microbiology Society's Microbiology Outlooks, launched in 2025, has published its inaugural article: "When Theory Meets Genomics: Reconciling Game Dynamics and Within-Host Evolution." The new ...

Since its launch in 2022, the programme has reduced the time to diagnosis from a global average of 7.6 years to just weeks.